|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4485045A
(en)
|
1981-07-06 |
1984-11-27 |
Research Corporation |
Synthetic phosphatidyl cholines useful in forming liposomes
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US4544545A
(en)
|
1983-06-20 |
1985-10-01 |
Trustees University Of Massachusetts |
Liposomes containing modified cholesterol for organ targeting
|
|
US5030719A
(en)
|
1986-08-28 |
1991-07-09 |
Teijin Limited |
Cytotoxic antibody conjugates and a process for preparation thereof
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5151510A
(en)
|
1990-04-20 |
1992-09-29 |
Applied Biosystems, Inc. |
Method of synethesizing sulfurized oligonucleotide analogs
|
|
ATE139900T1
(de)
|
1992-11-13 |
1996-07-15 |
Idec Pharma Corp |
Therapeutische verwendung von chimerischen und markierten antikörper gegen menschlichen b lymphozyt beschränkter differenzierung antigen für die behandlung von b-zell-lymphoma
|
|
EP0904386A2
(en)
|
1996-05-10 |
1999-03-31 |
Danisco A/S |
alpha-GLUCURONIDASES OF ASPERGILLUS, PRODUCTION THEREOF AND THEIR USES
|
|
AUPO930697A0
(en)
|
1997-09-19 |
1997-10-09 |
Walter And Eliza Hall Institute Of Medical Research, The |
Catalytic antibodies and a method of producing same
|
|
US6551795B1
(en)
|
1998-02-18 |
2003-04-22 |
Genome Therapeutics Corporation |
Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics
|
|
ES2299244T3
(es)
|
1998-05-13 |
2008-05-16 |
Domantis Limited |
Sistema de exposicion de fagos para la seleccion de proteinas correctamente plegadas.
|
|
US20030236190A1
(en)
*
|
1998-09-02 |
2003-12-25 |
Renuka Pillutla |
Isulin and IGF-1 receptor agonists and antagonists
|
|
US6875741B2
(en)
*
|
1998-09-02 |
2005-04-05 |
Renuka Pillutla |
Insulin and IGF-1 receptor agonists and antagonists
|
|
US7504490B1
(en)
|
1998-10-16 |
2009-03-17 |
Oscient Pharmaceuticals Corporation |
Nucleic acid and amino acid sequences relating to Apergillus fumigatus for diagnostics and therapeutics
|
|
AU4688499A
(en)
|
1998-10-23 |
2000-05-15 |
Human Genome Sciences, Inc. |
Fibroblast growth factor receptor-5
|
|
US20090087878A9
(en)
|
1999-05-06 |
2009-04-02 |
La Rosa Thomas J |
Nucleic acid molecules associated with plants
|
|
AU7833000A
(en)
*
|
1999-09-27 |
2001-04-30 |
Human Genome Sciences, Inc. |
38 human secreted proteins
|
|
CA2388019A1
(en)
*
|
1999-11-05 |
2001-05-17 |
Human Genome Sciences, Inc. |
24 human secreted proteins
|
|
WO2001055448A1
(en)
|
2000-01-31 |
2001-08-02 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
|
US6436703B1
(en)
*
|
2000-03-31 |
2002-08-20 |
Hyseq, Inc. |
Nucleic acids and polypeptides
|
|
US20110131679A2
(en)
*
|
2000-04-19 |
2011-06-02 |
Thomas La Rosa |
Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
|
|
WO2001092523A2
(en)
|
2000-05-30 |
2001-12-06 |
Curagen Corporation |
Human polynucleotides and polypeptides encoded thereby
|
|
EP1286700A2
(en)
|
2000-06-01 |
2003-03-05 |
Universite Catholique De Louvain |
Tumor activated prodrug compounds
|
|
WO2002006481A1
(fr)
*
|
2000-07-14 |
2002-01-24 |
Japan Science And Technology Corporation |
Cible d'un agent anticancereux
|
|
EP1328632A2
(en)
|
2000-08-04 |
2003-07-23 |
Eli Lilly And Company |
C1q-related factor, homologous polypeptides and therapeutic uses thereof
|
|
US7465790B2
(en)
|
2000-10-09 |
2008-12-16 |
Isis Innovation, Inc. |
Therapeutic antibodies
|
|
JP4334866B2
(ja)
|
2000-10-09 |
2009-09-30 |
アイシス イノヴェイション リミテッド |
治療用抗体
|
|
WO2002038796A2
(en)
|
2000-11-08 |
2002-05-16 |
Beth Israel Deaconess Medical Center, Inc. |
Methods for determining protease cleavage site motifs
|
|
US7214786B2
(en)
|
2000-12-14 |
2007-05-08 |
Kovalic David K |
Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
|
|
AU2002306849A1
(en)
|
2001-03-21 |
2002-10-08 |
Elitra Pharmaceuticals, Inc. |
Identification of essential genes in microorganisms
|
|
US7630836B2
(en)
*
|
2001-05-30 |
2009-12-08 |
The Kitasato Institute |
Polynucleotides
|
|
US20030134298A1
(en)
|
2001-07-03 |
2003-07-17 |
Madison Edwin L. |
Nucleic acid molecules encoding a transmembrane serine protease 20, the encoded polypeptides and methods based thereon
|
|
US20050208602A1
(en)
|
2001-08-10 |
2005-09-22 |
Rosen Craig A |
89 human secreted proteins
|
|
US7439319B2
(en)
|
2001-09-14 |
2008-10-21 |
Burnham Institute For Medical Research |
Selective substrates for matrix metalloproteinases
|
|
WO2003038083A1
(en)
|
2001-10-29 |
2003-05-08 |
Bayer Healthcare Ag |
Regulation of human type i adenylate cyclase
|
|
CA2475388A1
(en)
|
2002-02-14 |
2003-08-21 |
William J. Rutter |
Chimeric molecules for cleavage in a treated host
|
|
US20060009840A1
(en)
|
2002-03-15 |
2006-01-12 |
Hossainy Syed F |
Carrier for releasing a therapeutic substance in response to the presence of an enzyme
|
|
US20030194704A1
(en)
*
|
2002-04-03 |
2003-10-16 |
Penn Sharron Gaynor |
Human genome-derived single exon nucleic acid probes useful for gene expression analysis two
|
|
JP2003339385A
(ja)
*
|
2002-05-29 |
2003-12-02 |
Toyobo Co Ltd |
新規3−ヒドロキシ酪酸脱水素酵素遺伝子、新規3−ヒドロキシ酪酸脱水素酵素の製造法、ならびに、新規3−ヒドロキシ酪酸脱水素酵素を用いたケトン体の測定方法および測定用組成物
|
|
US20040109855A1
(en)
|
2002-07-23 |
2004-06-10 |
Herman Waldmann |
Therapeutic antibodies with reduced side effect
|
|
WO2004021861A2
(en)
|
2002-09-03 |
2004-03-18 |
Vit Lauermann |
Targeted release
|
|
US20040216190A1
(en)
*
|
2003-04-28 |
2004-10-28 |
Kovalic David K. |
Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
|
|
WO2004099254A2
(en)
|
2003-05-06 |
2004-11-18 |
The Government Of The United States, As Represented By The Secretary Of Health And Human Services |
Activation of recombinant diphtheria toxin fusion proteins by specific proteases highly expressed on the surface of tumor cells
|
|
US7276497B2
(en)
|
2003-05-20 |
2007-10-02 |
Immunogen Inc. |
Cytotoxic agents comprising new maytansinoids
|
|
US9079936B2
(en)
|
2003-07-01 |
2015-07-14 |
University Of Maryland, Baltimore |
Derivatives of APF and methods of use
|
|
WO2005090393A2
(en)
|
2004-02-09 |
2005-09-29 |
The Government Of The United States, As Represented By The Secretary Of Health And Human Services |
Multimeric protein toxins to target cells having multiple identifying characteristics
|
|
GB0417430D0
(en)
|
2004-08-05 |
2004-09-08 |
Uc3 |
A novel HPV vaccine comprising peptides from host cell proteins
|
|
US7572444B2
(en)
|
2004-12-20 |
2009-08-11 |
Amgen Fremont Inc. |
Binding proteins specific for human matriptase
|
|
AU2006226192A1
(en)
*
|
2005-03-19 |
2006-09-28 |
Medical Research Council |
Improvements in or relating to treatment and prevention of viral infections
|
|
AU2006235276A1
(en)
|
2005-04-07 |
2006-10-19 |
Novartis Vaccines And Diagnostics Inc. |
CACNA1E in cancer diagnosis, detection and treatment
|
|
WO2007027935A2
(en)
|
2005-08-31 |
2007-03-08 |
The Regents Of The University Of California |
Cellular libraries of peptide sequences (clips) and methods of using the same
|
|
KR101126423B1
(ko)
|
2005-10-21 |
2012-07-11 |
카탈리스트 바이오사이언시즈, 인코포레이티드 |
보체 활성화를 억제하는 변형된 프로테아제
|
|
EP1993608A1
(en)
|
2006-03-10 |
2008-11-26 |
Diatos |
Anticancer drugs conjugated to antibody via an enzyme cleavable linker
|
|
US20130332133A1
(en)
|
2006-05-11 |
2013-12-12 |
Ramot At Tel Aviv University Ltd. |
Classification of Protein Sequences and Uses of Classified Proteins
|
|
PT2845866T
(pt)
|
2006-10-27 |
2017-08-09 |
Genentech Inc |
Anticorpos e imunoconjugados e utilizações dos mesmos
|
|
TWI412367B
(zh)
|
2006-12-28 |
2013-10-21 |
梅達雷克斯有限責任公司 |
化學鏈接劑與可裂解基質以及其之綴合物
|
|
GB0724331D0
(en)
|
2007-12-13 |
2008-01-23 |
Domantis Ltd |
Compositions for pulmonary delivery
|
|
CA2688434A1
(en)
|
2007-06-06 |
2008-12-11 |
Domantis Limited |
Polypeptides, antibody variable domains and antagonists
|
|
CA2683801A1
(en)
|
2007-06-06 |
2008-12-11 |
Domantis Limited |
Polypeptides, antibody variable domains and antagonists
|
|
EP2190861A4
(en)
*
|
2007-08-22 |
2011-03-30 |
Univ California |
ACTIVE BINDING POLYPEPTIDES AND METHOD FOR THEIR IDENTIFICATION AND USE
|
|
GB0816447D0
(en)
*
|
2008-09-08 |
2008-10-15 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
GB0819287D0
(en)
|
2008-10-22 |
2008-11-26 |
Univ Bradford |
Compounds
|
|
US8895702B2
(en)
|
2008-12-08 |
2014-11-25 |
City Of Hope |
Development of masked therapeutic antibodies to limit off-target effects; application to anti-EGFR antibodies
|
|
EP3543256A1
(en)
|
2009-01-12 |
2019-09-25 |
Cytomx Therapeutics Inc. |
Modified antibody compositions, methods of making and using thereof
|
|
WO2010088691A2
(en)
|
2009-02-02 |
2010-08-05 |
Washington State University |
Compositions and methods for treating or preventing conditions and diseases associated with mannheimia haemolytica
|
|
DK3178835T3
(da)
|
2009-02-03 |
2019-06-24 |
Amunix Pharmaceuticals Inc |
Forlængede rekombinante polypeptider og sammensætninger omfattende samme
|
|
US8399219B2
(en)
|
2009-02-23 |
2013-03-19 |
Cytomx Therapeutics, Inc. |
Protease activatable interferon alpha proprotein
|
|
WO2010129609A2
(en)
|
2009-05-07 |
2010-11-11 |
The Regents Of The University Of California |
Antibodies and methods of use thereof
|
|
MX2012002719A
(es)
|
2009-09-02 |
2012-06-28 |
Univ Kansas State |
Ensayos opticos y de imagenes por resonancia magnetica (mri) para proteasas.
|
|
WO2011036297A2
(de)
*
|
2009-09-27 |
2011-03-31 |
Ruhr-Universität-Bochum |
Verfahren zur therapie und diagnose von morbus alzheimer
|
|
US8524220B1
(en)
|
2010-02-09 |
2013-09-03 |
David Gordon Bermudes |
Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria
|
|
US20110214205A1
(en)
|
2010-02-26 |
2011-09-01 |
Monsanto Technology Llc. |
Isolated Novel Nucleic Acid and Protein Molecules from Foxtail Millet and Methods of Using Those Molecules to Generate Transgenic Plants with Enhanced Agronomic Traits
|
|
BR112012029666A2
(pt)
|
2010-05-20 |
2020-10-06 |
Allergan, Inc. |
toxinas clostridiais degradáveis
|
|
GB201009271D0
(en)
|
2010-06-02 |
2010-07-21 |
Promar As |
Compositions
|
|
PL391627A1
(pl)
|
2010-06-25 |
2012-01-02 |
Adamed Spółka Z Ograniczoną Odpowiedzialnością |
Przeciwnowotworowe białko fuzyjne
|
|
BR112013002167A2
(pt)
|
2010-08-24 |
2016-05-31 |
Roche Glycart Ag |
anticorpo biespecífico, composição farmacêutica, uso, método de tratamento de um paciente que sofre de câncer e de um paciente que sofre de inflamação
|
|
US20120107894A1
(en)
*
|
2010-10-28 |
2012-05-03 |
Joule Unlimited Technologies, Inc. |
Methods and Compositions for the Recombinant Biosynthesis of Terminal Olefins
|
|
JP6096667B2
(ja)
*
|
2010-11-17 |
2017-03-15 |
ビーエーエスエフ ソシエタス・ヨーロピアBasf Se |
テルペンの生体触媒環化のための方法及びその方法で使用され得るシクラーゼ変異体
|
|
EP2709666B1
(en)
|
2011-05-16 |
2021-07-14 |
Koninklijke Philips N.V. |
Bio-orthogonal drug activation
|
|
JP6400470B2
(ja)
|
2011-05-16 |
2018-10-03 |
ジェネロン(シャンハイ)コーポレイション リミテッド |
多重特異性Fab融合タンパク質および使用法
|
|
US20140193342A1
(en)
|
2011-06-10 |
2014-07-10 |
The Regents Of The University Of California |
Enzyme directed assembly of particle theranostics
|
|
RU2639526C2
(ru)
|
2011-06-28 |
2017-12-21 |
ИНХИБРКС ЭлЭлСи |
Слитые полипептиды, содержащие домен wap, и способы их применения
|
|
WO2013138522A2
(en)
*
|
2012-03-16 |
2013-09-19 |
Genelux Corporation |
Methods for assessing effectiveness and monitoring oncolytic virus treatment
|
|
PE20150605A1
(es)
|
2012-04-27 |
2015-05-28 |
Cytomx Therapeutics Inc |
Anticuerpos activables que se unen al receptor del factor de crecimiento epidermico
|
|
AU2013270682A1
(en)
|
2012-06-08 |
2014-12-11 |
Biogen Ma Inc. |
Procoagulant compounds
|
|
SG11201408554QA
(en)
|
2012-06-22 |
2015-02-27 |
Cytomx Therapeutics Inc |
Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof
|
|
WO2013192546A1
(en)
|
2012-06-22 |
2013-12-27 |
Cytomx Therapeutics, Inc. |
Activatable antibodies having non-binding steric moieties and mehtods of using the same
|
|
EP2882844B1
(en)
|
2012-08-10 |
2018-10-03 |
Cytomx Therapeutics Inc. |
Protease-resistant systems for polypeptide display and methods of making and using thereof
|
|
US9487590B2
(en)
|
2012-09-25 |
2016-11-08 |
Cytomx Therapeutics, Inc. |
Activatable antibodies that bind interleukin-6 receptor and methods of use thereof
|
|
JP6605957B2
(ja)
|
2013-01-04 |
2019-11-13 |
シトムクス セラピューティクス,インコーポレイティド |
生体系におけるプロテアーゼ活性を検出するための組成物及び方法
|
|
US20140273089A1
(en)
*
|
2013-03-14 |
2014-09-18 |
Amgen, Inc. |
Fibroblast Growth Factor Receptor-Like Molecules and Uses Thereof
|
|
HK1215592A1
(zh)
*
|
2013-04-16 |
2016-09-02 |
Commonwealth Scientific And Industrial Research Organisation |
G蛋白偶联受体库
|
|
EP2988786A4
(en)
|
2013-04-22 |
2016-12-21 |
Avelas Biosciences Inc |
COMPOSITIONS FOR SELECTIVE DRUG ADMINISTRATION AND METHOD OF USE
|
|
SG11201509595PA
(en)
|
2013-05-28 |
2015-12-30 |
Dcb Usa Llc |
Antibody locker for the inactivation of protein drug
|
|
BR112015030514A2
(pt)
|
2013-06-04 |
2017-08-29 |
Cytomx Therapeutics Inc |
Composições e métodos para conjugação de anticorpos ativáveis
|
|
US12374421B2
(en)
*
|
2013-06-10 |
2025-07-29 |
Iogenetics, Llc |
Bioinformatic processes for determination of peptide binding
|
|
WO2014202616A2
(en)
|
2013-06-19 |
2014-12-24 |
Dsm Ip Assets B.V. |
Rasamsonia gene and use thereof
|
|
KR20250051130A
(ko)
|
2013-09-25 |
2025-04-16 |
싸이톰스 테라퓨틱스, 인크. |
매트릭스 메탈로프로테이나제 기질 및 다른 절단성 모이어티 및 이의 사용 방법
|
|
EP3628328B1
(en)
|
2014-01-31 |
2022-09-14 |
Cytomx Therapeutics Inc. |
Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof
|
|
KR102208963B1
(ko)
*
|
2014-05-14 |
2021-01-28 |
삼성전자주식회사 |
신규한 아크릴산 생성 경로를 갖는 미생물 및 이를 이용한 아크릴산 생산 방법
|
|
CA2955947A1
(en)
|
2014-07-25 |
2016-01-28 |
Cytomx Therapeutics, Inc. |
Anti-cd3 antibodies, activatable anti-cd3 antibodies, multispecific anti-cd3 antibodies, multispecific activatable anti-cd3 antibodies, and methods of using the same
|
|
MX2017004947A
(es)
|
2014-10-24 |
2017-06-29 |
Bristol Myers Squibb Co |
Polipeptidos del factor de crecimiento de fibroblastos 2 (fgf-21) modificados y usos de los mismos.
|
|
IL300408B2
(en)
*
|
2015-01-20 |
2025-11-01 |
Cytomx Therapeutics Inc |
Matrix metalloprotease-cleavable and serine protease cleavable substrates and methods of use thereof
|
|
KR20160107038A
(ko)
*
|
2015-03-03 |
2016-09-13 |
경남대학교 산학협력단 |
마이오신 아형을 분석하는 방법
|
|
MA42971A
(fr)
|
2015-03-13 |
2018-08-15 |
Cytomx Therapeutics Inc |
Anticorps anti-pdl1, anticorps anti-pld1 activables, et leurs procédés d'utilisation
|
|
AU2016258988A1
(en)
|
2015-05-04 |
2017-12-07 |
Cytomx Therapeutics, Inc |
Anti-ITGa3 antibodies, activatable anti-ITGa3 antibodies, and methods of use thereof
|
|
BR112017023872A2
(pt)
|
2015-05-04 |
2018-07-24 |
Cytomx Therapeutics Inc |
anticorpos anti-cd166, anticorpos anti-cd166 ativáveis e métodos de uso dos mesmos
|
|
TWI787796B
(zh)
|
2015-05-04 |
2022-12-21 |
美商Cytomx生物製藥公司 |
抗cd71抗體類、可活化之抗cd71抗體類及使用彼等之方法
|
|
CN107709356A
(zh)
|
2015-06-26 |
2018-02-16 |
南加利福尼亚大学 |
用于肿瘤特异性活化的掩蔽嵌合抗原受体t细胞
|
|
MX383464B
(es)
|
2015-07-13 |
2025-03-14 |
Cytomx Therapeutics Inc |
Anticuerpos anti-pd-1, anticuerpos anti-pd-1 activables, y métodos de uso de los mismos.
|
|
US20170191094A1
(en)
*
|
2015-12-31 |
2017-07-06 |
Synthetic Genomics, Inc. |
Expression of type i fatty acid synthase genes in eukaryotic algae
|
|
WO2017191274A2
(en)
|
2016-05-04 |
2017-11-09 |
Curevac Ag |
Rna encoding a therapeutic protein
|
|
US10337051B2
(en)
*
|
2016-06-16 |
2019-07-02 |
The Regents Of The University Of California |
Methods and compositions for detecting a target RNA
|
|
EP3526326A4
(en)
|
2016-10-12 |
2020-07-29 |
The Regents of The University of Colorado, A Body Corporate |
NEW MODIFIED AND CHEMERICAL NUCLEASES
|
|
EP3583217A4
(en)
*
|
2017-02-17 |
2021-04-07 |
Hyasynth Biologicals Inc. |
PROCESS AND CELL LINE FOR THE PRODUCTION OF POLYKETIDES IN YEAST
|
|
CN107723311A
(zh)
*
|
2017-11-28 |
2018-02-23 |
中国科学院遗传与发育生物学研究所 |
一种与植物种子粒重相关的TaCKX2‑3D蛋白及其编码基因与应用
|
|
WO2019161251A1
(en)
*
|
2018-02-15 |
2019-08-22 |
The Broad Institute, Inc. |
Cell data recorders and uses thereof
|
|
EP3864407A4
(en)
|
2018-10-11 |
2022-07-13 |
Northwestern University |
BIOMARKERS OF CHRONIC KIDNEY DISEASE IN LIVER TRANSPLANT RECIPIENTS
|
|
JP2022512124A
(ja)
|
2018-12-06 |
2022-02-02 |
シートムエックス セラピューティクス,インコーポレイテッド |
マトリックスメタロプロテアーゼ切断可能なおよびセリンまたはシステインプロテアーゼ切断可能な基質ならびにそれらの使用方法
|